Tag: Abatacept

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By
Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 23:53

Rituximab or JAK inhibitors increase the risk of severe COVID-19

Presented By
Dr Jeffrey Sparks, Brigham and Women’s Hospital, MA, USA
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 23:36

Updates on COVID-19 vaccines in patients with rheumatic disease

Presented By
Dr Victoria Furer, Tel Aviv Sourasky Medical Center, Israel
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 22:44

JAK inhibitors and bDMARDs show comparable effectiveness

Presented By
Mr Andrei Barbulescu, Karolinska Institutet, Sweden
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 10:23

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By
Prof. Joan Bathon, Columbia University, USA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:59

Abatacept prevents graft-versus-host disease in sickle cell patients after alloSCT

Presented By
Dr Niketa Shah, Yale University, USA
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 15:20

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:12

Interstitial lung disease in rheumatic diseases and systemic sclerosis

Presented By
Dr Jan Grutters, University Medical Center Utrecht, the Netherlands
Trial
SENSCIS, INPULSIS, SLS-2
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 23:50

Integrated 10-year analysis confirms safety profile abatacept

Presented By
Dr Teresa Simon, Bristol-Myers Squibb, USA
Trial
Cohort study, ARTIS, RABBIT, FORWARD, British Columbia Canadian RA Cohort
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 13:03

Combining new drugs with different mechanisms

Trial
EXPLORER
Conference
ECCO 2018
Type
Peer-reviewed article

28 May 2018 23:31
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com